-
VIR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Vir Biotechnology (VIR)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 318.70 mm | 318.70 mm | 318.70 mm | 318.70 mm | 318.70 mm | 318.70 mm |
Cash burn (monthly) | (no burn) | (no burn) | 39.05 mm | 48.93 mm | 29.21 mm | 37.20 mm |
Cash used (since last report) | n/a | n/a | 89.25 mm | 111.84 mm | 66.77 mm | 85.02 mm |
Cash remaining | n/a | n/a | 229.44 mm | 206.86 mm | 251.93 mm | 233.68 mm |
Runway (months of cash) | n/a | n/a | 5.9 | 4.2 | 8.6 | 6.3 |
13F holders | Current |
---|---|
Total holders | 214 |
Opened positions | 43 |
Closed positions | 29 |
Increased positions | 70 |
Reduced positions | 69 |
13F shares | Current |
---|---|
Total value | 642.68 bn |
Total shares | 128.60 mm |
Total puts | 234.50 k |
Total calls | 1.28 mm |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Softbank Vision Fund | 20.26 mm | $0.00 |
SB Investment Advisers | 16.68 mm | $122.46 bn |
BlackRock | 16.46 mm | $120.84 bn |
Vanguard | 13.13 mm | $96.38 bn |
ARCH Venture Fund IX | 12.92 mm | $369.42 mm |
GSK GSK | 6.63 mm | $199.31 mm |
STT State Street | 5.07 mm | $37.25 bn |
Orbimed Advisors | 3.22 mm | $23.62 bn |
Geode Capital Management | 2.20 mm | $16.13 bn |
Dimensional Fund Advisors | 1.92 mm | $14.06 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Feb 25 | Verneuil Vanina de | Common Stock | Sell | Dispose S | No | Yes | 9.1418 | 7,373 | 67.40 k | 79,460 |
24 Feb 25 | Ann M. Hanly | Common Stock | Sell | Dispose S | No | No | 9.4534 | 14,168 | 133.94 k | 117,901 |
24 Feb 25 | Scangos George A | Common Stock | Sell | Dispose S | No | No | 9.4534 | 10,056 | 95.06 k | 698,239 |
24 Feb 25 | Verneuil Vanina de | Common Stock | Sell | Dispose S | No | No | 9.4534 | 5,140 | 48.59 k | 86,833 |
24 Feb 25 | Backer Marianne De | Common Stock | Sell | Dispose S | No | No | 9.4534 | 16,122 | 152.41 k | 849,217 |
22 Feb 25 | Verneuil Vanina de | Common Stock | Grant | Acquire A | No | No | 0 | 35,000 | 0.00 | 91,973 |
22 Feb 25 | Verneuil Vanina de | Stock Option (Right to Buy) Common Stock | Grant | Acquire A | No | No | 9.57 | 70,000 | 669.90 k | 70,000 |
22 Feb 25 | Backer Marianne De | Common Stock | Grant | Acquire A | No | No | 0 | 240,000 | 0.00 | 865,339 |
22 Feb 25 | Backer Marianne De | Stock Option (Right to Buy) Common Stock | Grant | Acquire A | No | No | 9.57 | 480,000 | 4.59 mm | 480,000 |